August 28th, 2013
Platelet Reactivity Testing: Do You or Don’t You?
Richard A. Lange, MD, MBA and L. David Hillis, MD
In light of recent findings from the ADEPT DES study, Richard Lange and David Hillis want to know: Do you test PCI patients for platelet reactivity, and if so, why? React to reactivity in our latest poll.
September 4th, 2012
Danish Survey Finds Clopidogrel Less Effective in Diabetics
Larry Husten, PHD
A large nationwide survey of MI survivors in Denmark provides new information about the efficacy of antiplatelet therapy with clopdiogrel in patients with diabetes. In a paper published in JAMA, Charlotte Andersson reports on 58,851 MI patients, 12% of whom had diabetes and 60% of whom received clopidogrel. As expected, diabetics had a worse outcome than nondiabetics: the composite […]
April 19th, 2012
Should We Pull the Trigger on Platelet Reactivity Testing (and Put It out of Its Misery)?
Richard A. Lange, MD, MBA and L. David Hillis, MD
“We said it before, and we’ll say it again: an assessment of platelet reactivity by this method doesn’t effectively identify individuals at high risk for a cardiovascular event following PCI.”
NEJM Journal Watch — Recent Cardiology Articles- Transcatheter Valve Replacement for Severe Tricuspid Regurgitation
- Time in Blood Pressure Target Range and Outcomes in Hypertension: Real-World Data
- When to Start Anticoagulation After Ischemic Stroke in Patients with Atrial Fibrillation
- Aortic-Valve Replacement vs. Clinical Surveillance for Asymptomatic Severe Aortic Stenosis
- Secondary Hypertension in Young Adults